|
Hormone Predicts Death Risk in Kidney Patients - Ivanhoe |
Ivanhoe
(Ivanhoe Newswire) – High levels of a hormone, FGF-23, can predict which kidney patients will develop heart problems, require dialysis, or die prematurely, according to this study. "This discovery allows us to predict at-risk patients before they
|
|
Chronic kidney disease set to soar in Aust - Sydney Morning Herald |
Sydney Morning Herald
Demand for kidney transplants and dialysis is expected to soar by 2020 amid a spike in diabetics developing chronic kidney disease and needing treatment. The total number of Australians being treated for end-stage kidney disease is forecast to rise by
|
Sensipar gets FDA label change focusing on hypocalcemia monitoring and seizure risk. |
FDA: WARNINGS AND PRECAUTIONS................ Seizures ----In clinical studies, seizures (primarily generalized or tonic-clonic) were observed in 1.4% (43/3049) of Sensipar-treated patients and 0.7% (5/687) of placebo-treated patients. While the basis for the reported difference in seizure rate is not clear, the threshold for seizures is lowered by significant reductions in serum calcium levels. Therefore, serum calcium levels should be closely monitored in patients receiving Sensipar, particularly in patients with a history of a seizure disorder.
|
Doctors at NIMS allege recruitment and promotion policy faulty, against norms - pharmabiz.com |
pharmabiz.com
Senior doctors allege that posts of assistant and associate professors in the neurology, nephrology and cardiology departments are being filled without issuing the mandatory notification. Such actions are in violation of norms laid down by Medical
|
Stored blood samples from CKD homocysteine study show that FGF-23 is risk factor for ESRD, death |
JASN: In conclusion, in advanced CKD, FGF-23 strongly and independently associates with all-cause mortality, cardiovascular events, and initiation of chronic dialysis.
|
|
|
|
<< Start < Prev 701 702 703 704 705 706 707 708 709 710 Next > End >>
|
Page 703 of 2630 |